Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

AQSTAQST
16 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in AQUESTIVE THERAPEUTICS INC

Yes. Goldman Sachs holds 468,569 shares of AQST (Aquestive Therapeutics), worth $1.9M, as of its Q2 2026 13F filing. It increased the position by 1,802 shares (+0.4%) from Q1 2026. Goldman Sachs has held AQST since Q4 2023, across 11 quarterly 13F filings.

Current Value

$1.9M

Current Shares

468,569

Total Value Change

+$1.9M

Total Shares Change

+454,410

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
468,569
+0.4%
$1.9M0.0%$4.16
26
2026-Q1
Decreased
466,767
-48.6%
$1.9M0.0%$4.15
0
2025-Q4
Increased
909,064
+130.1%
$5.9M0.0%$6.46
44
2025-Q3
Decreased
395,150
-24.7%
$2.2M0.0%$5.59
0
2025-Q2
Decreased
524,685
-35.9%
$1.7M0.0%$3.31
0
2025-Q1
Decreased
818,849
-6.6%
$2.4M0.0%$2.90
0
2024-Q4
Increased
876,537
+293.6%
$3.1M0.0%$3.56
43
2024-Q3
Increased
222,687
+95.3%
$1.1M0.0%$4.98
40
2024-Q2
Decreased
114,009
-78.3%
$296,4230.0%$2.60
0
2024-Q1
Increased
526,422
+1626.0%
$2.2M0.0%$4.26
42
2023-Q4
New
30,499
-
$61,6080.0%$2.02
32
2023-Q3
Exited
0
-100.0%
$00.0%$1.53
0
2023-Q2
New
57,149
-
$94,2960.0%$1.65
33
2022-Q4
Exited
0
-100.0%
$00.0%$0.90
0
2022-Q3
Increased
27,704
+95.7%
$320.0%$1.17
12
2022-Q2
First report
14,159
-
$90.0%$0.64
0

Other major holders of AQST: BlackRock, Inc., RTW INVESTMENTS, LP, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used